HEADER TRANSLATION 08-FEB-19 6NX4 TITLE STRUCTURE OF THE C-TERMINAL HELICAL REPEAT DOMAIN OF EUKARYOTIC TITLE 2 ELONGATION FACTOR 2 KINASE (EEF-2K) COMPND MOL_ID: 1; COMPND 2 MOLECULE: EUKARYOTIC ELONGATION FACTOR 2 KINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: 562-725 C-TERMINAL FRAGMENT; COMPND 5 SYNONYM: EEF-2K,CALCIUM/CALMODULIN-DEPENDENT EUKARYOTIC ELONGATION COMPND 6 FACTOR 2 KINASE; COMPND 7 EC: 2.7.11.20; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EEF2K; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-26B KEYWDS EEF2K, EEF2, BINDING DOMAIN, KINASE, TRANSFERASE, SEL1, ELONGATION, KEYWDS 2 TPR, TRANSLATION EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR A.PISERCHIO,N.WILL,D.H.GILES,F.HAJREDINI,K.N.DALBY,R.GHOSE REVDAT 4 01-MAY-24 6NX4 1 REMARK REVDAT 3 18-DEC-19 6NX4 1 REMARK REVDAT 2 10-JUL-19 6NX4 1 JRNL REVDAT 1 29-MAY-19 6NX4 0 JRNL AUTH A.PISERCHIO,N.WILL,D.H.GILES,F.HAJREDINI,K.N.DALBY,R.GHOSE JRNL TITL SOLUTION STRUCTURE OF THE CARBOXY-TERMINAL TANDEM REPEAT JRNL TITL 2 DOMAIN OF EUKARYOTIC ELONGATION FACTOR 2 KINASE AND ITS ROLE JRNL TITL 3 IN SUBSTRATE RECOGNITION. JRNL REF J.MOL.BIOL. V. 431 2700 2019 JRNL REFN ESSN 1089-8638 JRNL PMID 31108082 JRNL DOI 10.1016/J.JMB.2019.05.019 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA REMARK 3 AUTHORS : LINGE, O'DONOGHUE AND NILGES REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: EXPLICIT WATER REMARK 4 REMARK 4 6NX4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-FEB-19. REMARK 100 THE DEPOSITION ID IS D_1000239517. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298.15 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 20 MM PHOSPHATE 100 MM NACL REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 200 UM [U-99% 13C; U-99% 15N] REMARK 210 EEF2K (562-725), 20 MM SODIUM REMARK 210 PHOSPHATE, 100 MM SODIUM REMARK 210 CHLORIDE, 4 MM DTT, 0.2 MM EDTA, REMARK 210 2 MM AEBSF PROTEASE INHIBITOR, REMARK 210 95% H2O/5% D2O; 360 UM [U-99% REMARK 210 13C; U-99% 15N] EEF2K (562-725), REMARK 210 20 MM SODIUM PHOSPHATE, 100 MM REMARK 210 SODIUM CHLORIDE, 4 MM DTT, 0.2 REMARK 210 MM EDTA, 2 MM AEBSF PROTEASE REMARK 210 INHIBITOR, 95% H2O/5% D2O; 400 REMARK 210 UM [U-99% 13C; U-99% 15N] EEF2K REMARK 210 (562-725), 20 MM SODIUM REMARK 210 PHOSPHATE, 100 MM SODIUM REMARK 210 CHLORIDE, 4 MM DTT, 0.2 MM EDTA, REMARK 210 2 MM AEBSF PROTEASE INHIBITOR, REMARK 210 95% H2O/5% D2O; 340 UM [U-99% REMARK 210 13C; U-99% 15N] EEF2K (562-725), REMARK 210 14 MG/ML PF1 PHAGE, 14 MM SODIUM REMARK 210 PHOSPHATE, 100 MM SODIUM REMARK 210 CHLORIDE, 4 MM DTT, 0.2 MM EDTA, REMARK 210 2 MM AEBSF PROTEASE INHIBITOR, REMARK 210 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D 1H-15N NOESY; 4D HC-HSQC REMARK 210 -NOESY-HN-HSQC; 3D 3D NNH (15N- REMARK 210 HSQC-NOESY-15N-HSQC; 3D 1H-13C REMARK 210 NOESY ALIPHATIC; 3D H-13C NOESY REMARK 210 AROMATIC; 3D HNCO; 3D HNCA; 3D REMARK 210 HN(CO)CA; 3D HNCACB; 3D CBCA(CO) REMARK 210 NH; 3D HN(CA)CO; 3D HCC(CO)NH; REMARK 210 3D HCCH-TOCSY; 2D 15N HSQC-IPAP; REMARK 210 3D IPAP-J-HNCO REMARK 210 SPECTROMETER FIELD STRENGTH : 900 MHZ; 800 MHZ; 700 MHZ; 600 REMARK 210 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, SMILE, NMRVIEW, TALOSN, REMARK 210 PALES REMARK 210 METHOD USED : MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 1000 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 HIS A 560 39.43 -146.82 REMARK 500 1 LEU A 564 78.57 58.45 REMARK 500 1 LEU A 577 103.34 65.05 REMARK 500 1 LYS A 596 35.97 -99.77 REMARK 500 1 SER A 627 138.50 75.27 REMARK 500 1 GLU A 652 49.81 -90.76 REMARK 500 1 GLU A 655 78.93 -108.27 REMARK 500 1 TYR A 680 88.61 59.19 REMARK 500 2 LEU A 564 -59.96 -130.16 REMARK 500 2 LEU A 570 73.48 58.11 REMARK 500 2 ALA A 583 139.92 -170.13 REMARK 500 2 GLU A 589 -46.08 -165.16 REMARK 500 2 SER A 627 135.43 71.11 REMARK 500 2 PRO A 628 5.29 -67.25 REMARK 500 2 TYR A 680 73.14 57.50 REMARK 500 3 MET A 561 76.56 63.02 REMARK 500 3 LYS A 596 47.68 -102.11 REMARK 500 3 GLN A 624 -74.77 -56.47 REMARK 500 3 SER A 627 133.32 72.30 REMARK 500 3 PRO A 628 1.16 -64.75 REMARK 500 3 ASP A 657 39.39 -94.07 REMARK 500 4 VAL A 568 76.71 -117.66 REMARK 500 4 LEU A 570 -44.15 72.03 REMARK 500 4 MET A 573 61.90 62.85 REMARK 500 4 SER A 627 143.77 72.79 REMARK 500 4 MET A 647 31.95 -96.06 REMARK 500 4 CYS A 650 33.05 -89.85 REMARK 500 4 MET A 659 62.79 -106.75 REMARK 500 4 LYS A 705 75.58 -106.85 REMARK 500 5 SER A 575 -59.94 -153.01 REMARK 500 5 LEU A 582 56.61 -91.05 REMARK 500 5 ALA A 583 45.32 -145.91 REMARK 500 5 VAL A 585 52.89 -92.14 REMARK 500 5 GLN A 624 -75.00 -74.91 REMARK 500 5 SER A 627 132.24 71.94 REMARK 500 5 PRO A 628 5.06 -66.78 REMARK 500 5 TYR A 680 61.05 64.47 REMARK 500 5 MET A 723 87.88 -67.77 REMARK 500 6 SER A 627 131.00 71.92 REMARK 500 6 THR A 677 -61.74 -91.30 REMARK 500 6 TYR A 680 77.92 47.56 REMARK 500 6 LYS A 705 76.97 -104.75 REMARK 500 7 GLU A 563 26.54 -142.21 REMARK 500 7 LEU A 587 -59.99 -120.75 REMARK 500 7 THR A 590 54.60 -142.32 REMARK 500 7 SER A 627 137.94 70.37 REMARK 500 7 PRO A 628 3.12 -65.92 REMARK 500 7 MET A 647 30.27 -93.96 REMARK 500 7 LYS A 705 79.95 -108.12 REMARK 500 8 GLU A 563 62.22 -105.00 REMARK 500 REMARK 500 THIS ENTRY HAS 165 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30569 RELATED DB: BMRB REMARK 900 STRUCTURE OF THE C-TERMINAL HELICAL REPEAT DOMAIN OF EUKARYOTIC REMARK 900 ELONGATION FACTOR 2 KINASE (EEF-2K) DBREF 6NX4 A 562 725 UNP O00418 EF2K_HUMAN 562 725 SEQADV 6NX4 SER A 559 UNP O00418 EXPRESSION TAG SEQADV 6NX4 HIS A 560 UNP O00418 EXPRESSION TAG SEQADV 6NX4 MET A 561 UNP O00418 EXPRESSION TAG SEQRES 1 A 167 SER HIS MET GLY GLU LEU GLU ALA ILE VAL GLY LEU GLY SEQRES 2 A 167 LEU MET TYR SER GLN LEU PRO HIS HIS ILE LEU ALA ASP SEQRES 3 A 167 VAL SER LEU LYS GLU THR GLU GLU ASN LYS THR LYS GLY SEQRES 4 A 167 PHE ASP TYR LEU LEU LYS ALA ALA GLU ALA GLY ASP ARG SEQRES 5 A 167 GLN SER MET ILE LEU VAL ALA ARG ALA PHE ASP SER GLY SEQRES 6 A 167 GLN ASN LEU SER PRO ASP ARG CYS GLN ASP TRP LEU GLU SEQRES 7 A 167 ALA LEU HIS TRP TYR ASN THR ALA LEU GLU MET THR ASP SEQRES 8 A 167 CYS ASP GLU GLY GLY GLU TYR ASP GLY MET GLN ASP GLU SEQRES 9 A 167 PRO ARG TYR MET MET LEU ALA ARG GLU ALA GLU MET LEU SEQRES 10 A 167 PHE THR GLY GLY TYR GLY LEU GLU LYS ASP PRO GLN ARG SEQRES 11 A 167 SER GLY ASP LEU TYR THR GLN ALA ALA GLU ALA ALA MET SEQRES 12 A 167 GLU ALA MET LYS GLY ARG LEU ALA ASN GLN TYR TYR GLN SEQRES 13 A 167 LYS ALA GLU GLU ALA TRP ALA GLN MET GLU GLU HELIX 1 AA1 PHE A 598 ALA A 607 1 10 HELIX 2 AA2 ARG A 610 ASP A 621 1 12 HELIX 3 AA3 TRP A 634 MET A 647 1 14 HELIX 4 AA4 ARG A 664 THR A 677 1 14 HELIX 5 AA5 PRO A 686 ALA A 703 1 18 HELIX 6 AA6 GLY A 706 GLN A 722 1 17 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1